The biopharmaceutical industry is responsible for creating some of the most important drugs in the world. Through complex research, trials, and manufacturing, the biopharma sector continues to make groundbreaking discoveries that change lives.
Companies around the world are engaging with GMP mRNA manufacturing processes to solve complex health issues from arthritis to breast cancer.
Read on to discover the top six biopharmaceutical drugs and find out how they’ve revolutionized the health space.
HUMIRA
The best-selling pharmaceutical drug in the world is HUMIRA. It was designed to ease the challenges of rheumatoid arthritis and enjoys strong success – with 63% of people who take HUMIRA seeing improvements in their symptoms.
Rheumatoid arthritis affects over 1.3 million Americans and as many as 1% of the worldwide population – meaning its importance cannot be overstated.
HUMIRA is also approved for other forms of arthritis, including psoriatic arthritis, as well as other illnesses including Crohn’s disease, ankylosing spondylitis, hidradenitis suppurativa, and plaque psoriasis.
Lantus
Launched in 2000, Lantus is a long-acting form of insulin and is perhaps the most famous biopharmaceutical drug of all. It was developed in Germany and is used to combat diabetes. Every day, millions of people rely on Lantus to ease the symptoms of their diabetes condition.
Diabetes is one of the most prominent ills experienced by the population and it affects people of all ages. The proportion of people getting diabetes increases every year. 1 in 5 people don’t even know they have it, but it is the seventh leading cause of death.
REMICADE
REMICADE was manufactured by a subsidiary of Johnson & Johnson prior to the new millennium and has vast global sales each year.
REMICADE is another biopharmaceutical drug that was developed to beat rheumatoid arthritis and Crohn’s disease, as well as plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
AVONEX
Back in 1996, the manufacturer Biogen Idec created AVONEX. This groundbreaking biopharma industry invention is approved for multiple sclerosis – the most common demyelinating disease.
AVONEX is a once-a-week injectable treatment prescribed to over 590,000 people worldwide.
Avastin
Launched in 2004 and with global sales of over $7 billion each year, this drug created by the company Roche was once one of the most expensive drugs on the market at $4,400 per month.
Avastin is used by cervical, hepatocellular, lung, and metastatic colorectal cancer sufferers. It is also approved for epithelial ovarian, fallopian tubes, and peritoneal cancer.
Avastin is a tumor-starving therapy that blocks a protein called VEGF. This starvation can prevent the growth of new blood vessels that feed tumors.
Herceptin
Used to combat the effects of breast cancer, Herceptin was launched in 1998 after years of research and manufacturing.
Herceptin went through seven Phase II or III clinical trials to ensure it was safe for consumers. Over the last 25 years, this biopharmaceutical creation has treated 2.3 million patients worldwide.
